Price
No data yet.
Social Signal Score
Analyst Ratings
46 analystsRevenue
$19.85B+86.53%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Samuel N. Hazen
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 320,000
- Beta
- 1.11
- Country
- US
- Piotroski score
- 6 / 9 (Middling)
- Altman Z-score
- 2.49
Financials
Revenue
$19.85B+86.5%Net Income
$1.58B+71.6%EBITDA
$3.93B+57.2%Free Cash Flow
$3.10B+277.2%EPS (diluted)
$7.27+204.2%Shares Outstanding (diluted)
217.21M-43.5%Operating Expenses
$7.86BCash & Debt
$908.00MReturn of Capital
$3.13BRevenue by Segment (annual)
$73.14BDividend per Share
$0.78Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $75.60B | $6.78B | $28.70 |
| 2024 | $70.60B | $5.76B | $22.27 |
| 2023 | $64.97B | $5.24B | $19.24 |
| 2022 | $60.23B | $5.64B | $19.44 |
| 2021 | $58.75B | $6.96B | $21.51 |
| 2020 | $51.53B | $3.75B | $11.08 |
| 2019 | $51.34B | $3.50B | $10.27 |
| 2018 | $46.68B | $3.79B | $11.04 |
| 2017 | $43.61B | $2.22B | $6.33 |
| 2016 | $41.49B | $2.89B | $7.80 |
| 2015 | $39.68B | $2.13B | $5.34 |
| 2014 | $36.92B | $1.88B | $4.46 |
| 2013 | $34.18B | $1.56B | $3.54 |
| 2012 | $33.01B | $1.60B | $3.62 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from HCA's reported EPS growth of 17.3% a year over 13 years.
- EPS in 5 years
- $63.72
- Implied price
- $1,020
- Return from $460.33
- 17.2% a year
To earn 15.0% a year on these assumptions you'd need to buy at $506.92 — today's price is already 9.2% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 14 | 16 | 18 | 20 |
|---|---|---|---|---|---|
| 7.3% | 1.2% | 4.4% | 7.2% | 9.8% | 12.1% |
| 12.3% | 6.0% | 9.3% | 12.2% | 14.9% | 17.4% |
| 17.3% | 10.7% | 14.1% | 17.2% | 20.0% | 22.6% |
| 22.3% | 15.4% | 19.0% | 22.2% | 25.1% | 27.8% |
| 27.3% | 20.1% | 23.9% | 27.2% | 30.3% | 33.0% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
70+16.67%Social Signal Score
Mentions (41)
- Newszacks.com·2d ago·Positive
Here's Why HCA Healthcare (HCA) is a Strong Growth Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
View source ↗ - Newszacks.com·5d ago·Positive
Why HCA Healthcare (HCA) is a Top Stock for the Long-Term Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
View source ↗ - Newszacks.com·6d ago·Positive
Why HCA Healthcare (HCA) is a Top Momentum Stock for the Long-Term Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
View source ↗ - News (RSS)fool·15d ago·Positive
HCA Healthcare: 3 Key Takeaways for Long-Term Investors Cost discipline and digital initiatives must offset payer mix headwinds for HCA to hit multiyear growth targets.
View source ↗ - Newsfool.com·15d ago·Neutral
HCA Healthcare: 3 Key Takeaways for Long-Term Investors Same facility equivalent admissions increased 3% in the third quarter. HCA Healthcare repurchased approximately $3 billion of outstanding shares.
View source ↗ - Newszacks.com·16d ago·Positive
Earnings Growth & Price Strength Make HCA Healthcare (HCA) a Stock to Watch The Zacks Focus List offers investors a way to easily find top-rated stocks and build a winning investment portfolio. Here's why you should take advantage.
View source ↗ - Newszacks.com·17d ago·Positive
HCA Healthcare (HCA) Just Flashed Golden Cross Signal: Do You Buy? HCA Healthcare (HCA) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, HCA broke through the 20-day moving average, which suggests a short-term bullish trend.
View source ↗ - News (RSS)economictimes·18d ago·Neutral
… in a Democrat-led Congress, analysts project the funding could fall short of expectations.HEALTH INSURERS AND HOSPITAL OPERATORSShares of hospital operators such as HCA Healthcare and Universal Health Services gained 5.4% and 3.4%, respectively.Insurers such as Centene rose 4.7% and Elevance was marginally higher.Democrats have pushed for universal healthcare policies that could mean more government spending allocated to the sector.BNP Paribas economist Anis Bensaidani said Democrats may lack t…
View source ↗ - Newszacks.com·18d ago·Positive
Why HCA Healthcare (HCA) is a Top Growth Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
View source ↗ - News (RSS)seekingalpha·25d ago·Neutral
HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track
View source ↗ - Newsseekingalpha.com·25d ago·Positive
HCA Healthcare: Payer Mix Pressures, But Broad Trends On Track HCA Healthcare, Inc. is reiterated at Hold, with shares trading near fair value and a mixed technical outlook. Q3 results beat expectations: non-GAAP EPS of $7.22 and revenue of $19.9B, driven by strong volume growth and the Virginia SDP program impact. Management raised FY guidance to the upper half of prior range, but ongoing payer mix pressures and Medicaid headwinds persist.
View source ↗ - Newsseekingalpha.com·26d ago·Positive
HCA Healthcare, Inc. (HCA) Q3 2026 Earnings Call Transcript HCA Healthcare, Inc. ( HCA ) Q3 2026 Earnings Call October 27, 2026 10:00 AM EDT Company Participants Frank Morgan - Vice President of Investor Relations Samuel Hazen - CEO & Director Mike Marks - CFO & Executive VP Conference Call Participants Albert Rice - UBS Investment Bank, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Brian Tanquilut - Jefferies…
View source ↗ - 4chan /biz/biz·26d ago·Negative
I bought some HCA. they maintained guidence and are down 5% today. just some selloff of healthcare to buy tech. definitely a good entry
View source ↗ - Newsmarketbeat.com·26d ago·Negative
What HCA Healthcare (HCA) Said on Its Q3 Earnings Call HCA Healthcare NYSE: HCA said third-quarter results modestly exceeded its expectations as admissions growth, improved insured revenue per admission and disciplined cost management helped offset pressure from patients losing health insurance exchange coverage.
View source ↗ - Newszacks.com·26d ago·Neutral
HCA Healthcare Q3 Earnings Beat Estimates on Higher Admissions HCA's Q3 earnings and revenues beat estimates on higher admissions and ER visits, while rising costs and fewer surgeries temper growth.
View source ↗ - Newszacks.com·26d ago·Neutral
HCA (HCA) Reports Q3 Earnings: What Key Metrics Have to Say Although the revenue and EPS for HCA (HCA) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
View source ↗ - News (RSS)investing·26d ago·Neutral
Why is HCA Healthcare stock surging today?
View source ↗ - Newszacks.com·26d ago·Positive
HCA Healthcare (HCA) Q3 Earnings and Revenues Top Estimates HCA Healthcare (HCA) came out with quarterly earnings of $7.22 per share, beating the Zacks Consensus Estimate of $6.74 per share. This compares to earnings of $6.96 per share a year ago.
View source ↗ - Newswsj.com·26d ago·Negative
HCA Healthcare Profit Slips but Revenue Rises The operator of healthcare facilities on posted net income of $1.58 billion, compared with $1.64 billion in the same quarter a year ago.
View source ↗ - Newszacks.com·27d ago·Positive
Why Investors Need to Take Advantage of These 2 Medical Stocks Now Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
View source ↗ - Newszacks.com·31d ago·Neutral
Countdown to HCA (HCA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS Evaluate the expected performance of HCA (HCA) for the quarter ended September 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
View source ↗ - Newszacks.com·31d ago·Negative
Will HCA Healthcare's Q3 Earnings Benefit From Higher Admissions? HCA's Q3 results could benefit from higher admissions, occupancy and inpatient revenues, but rising costs and fewer outpatient surgeries cloud the outlook.
View source ↗ - News (Marketaux)seekingalpha.com·39d ago·Neutral
IHF: A Concentrated And Volatile ETF In Healthcare Providers (NYSEARCA:IHF) Ticker Name Weight (%) UNH UNITEDHEALTH [+347 characters]
View source ↗ - Newsseekingalpha.com·40d ago·Neutral
HCA Healthcare Is Too Healthy To Downgrade HCA Healthcare remains a "Buy," supported by strong revenue growth and favorable demographic trends in healthcare demand. Despite some margin pressures from payer mix shifts, HCA's revenue per equivalent admission rose 6% and occupancy improved year-over-year. Management anticipates 2026 revenue growth to $77–$79.5 billion, though net income and EBITDA guidance have been revised slightly lower.
View source ↗ - Newsbusinesswire.com·53d ago·Neutral
HCA Healthcare, Inc. 3rd Quarter 2026 Earnings Conference Call NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q 2026 Earnings Call When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, frank.morgan@hcahealthcare.com If y…
View source ↗ - Newsbusinesswire.com·54d ago·Positive
HCA Healthcare Presents 2026 Awards of Distinction NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of Distinction, which include the Frist Humanitarian Award and the Excellence in Nursing Award, are the highest honors HCA Healthcare bestows on colleagues, nurses, physicians and volunteers, recognizin…
View source ↗ - Newszacks.com·55d ago·Negative
Can Shorter Hospital Stays Help HCA Handle More Patient Demand? HCA's rising admissions and shorter hospital stays could help it meet growing patient demand while using existing capacity more efficiently.
View source ↗ - Newszacks.com·59d ago·Neutral
Can HCA Sustain Earnings Growth Despite a Changing Service Mix? HCA Healthcare's healthy volume growth faces payer-mix pressure, but cost controls, network expansion and Medicaid payments may support earnings growth.
View source ↗ - Newsdefenseworld.net·59d ago·Neutral
Critical Survey: HCA Healthcare (NYSE:HCA) and Labcorp (NYSE:LH) HCA Healthcare (NYSE: HCA - Get Free Report) and Labcorp (NYSE: LH - Get Free Report) are both large-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, risk, valuation, profitability and institutional ownership. Dividends HCA Healthcare pays an annual dividend of
View source ↗ - News (Marketaux)gurufocus.com·61d ago·Positive
HCA Looks 5.0% Undervalued on GF Value™ as Insider Selling Raises Caution On September 22, 2026, BMO Capital initi[+292 characters]
View source ↗ - News (RSS)seekingalpha·62d ago·Neutral
HCA Healthcare: Hold Until The Noise Clears
View source ↗ - News (RSS)yahoo·63d ago·Neutral
HCA Healthcare (HCA) Acquires a Healthcare College. Can Training Capacity Improve Staffing?
View source ↗ - Newsmarketbeat.com·65d ago·Neutral
HCA Healthcare Sees Solid Demand as Exchange Headwinds Pressure 2026 Outlook HCA Healthcare NYSE: HCA CFO Mike Marks said the hospital operator is navigating a changing policy environment in 2026 while continuing to see solid underlying demand for services outside of the health insurance exchanges.
View source ↗ - News (RSS)yahoo·67d ago·Negative
Alluvium Increases HCA Healthcare (HCA) Holdings After Its 17.5% Selloff
View source ↗ - Newsseekingalpha.com·67d ago·Positive
HCA Healthcare, Inc. (HCA) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript HCA Healthcare, Inc. (HCA) Presents at 2026 Jefferies Healthcare Services and Technology Conference Transcript
View source ↗ - News (RSS)investing·68d ago·Neutral
HCA Healthcare completes acquisition of health college CHCP
View source ↗ - Newsbusinesswire.com·69d ago·Neutral
MEDITECH Expanse EHR Live Across First Full U.S. Divisions of HCA Healthcare CANTON, Mass.--(BUSINESS WIRE)-- #Expanse--MEDITECH has completed implementation of its Expanse EHR platform across 34 hospitals in HCA Healthcare's Capital and North Florida divisions.
View source ↗ - Newsseekingalpha.com·74d ago·Positive
HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript HCA Healthcare, Inc. (HCA) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
View source ↗ - News (RSS)yahoo·82d ago·Neutral
HCA Healthcare (HCA) Navigates Patient Volume Challenges While Reporting Growth
View source ↗ - Newszacks.com·86d ago·Positive
Can Operational Resiliency Protect HCA's Long-Term Profitability? HCA Healthcare's resiliency program is helping control costs amid payer pressures, potentially supporting long-term profitability and EBITDA growth.
View source ↗ - Newsbusinesswire.com·94d ago·Neutral
HCA Healthcare, Inc. to Present at September Conferences NASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) is scheduled to present at the following healthcare conferences: September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference September 15, 2026, at 1:50pm CT at the Jefferies Healthcare Conference A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the…
View source ↗
Earnings
Tue, Jan 26(in 2 months)
Consensus estimate $8.17 per share
Typical surprise +8.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 27$7.22 vs $6.65beat
- Fri, Jul 24$7.59 vs $7.56beat
- Fri, Apr 24$7.15 vs $7.12beat
- Tue, Jan 27$8.01 vs $7.46beat
- Fri, Oct 24$6.96 vs $5.79beat
- Fri, Jul 25$6.84 vs $6.29beat
Estimates and results for HCA via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by HCA officers and directors.
- Bought
- —
- Sold
- $25.3m
0 trades
14 trades
- Rossitto Ericasold
- Foster Jon Msold
- Foster Jon Msold
- Foster Jon Msold
- Foster Jon Msold
- Foster Jon Msold
- Foster Jon Msold
- Foster Jon Msold
86 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
- Ro Khannahouse · CA17 · disclosed Oct 9, 2026 (35d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jul 27, 2026 (40d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jul 27, 2026 (40d later)Buy$1,001 - $15,000
- Alan Armstrongsenate · disclosed Jul 21, 2026 (116d later)Buy$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 14, 2025 (18d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Oct 22, 2025 (41d later)Sell$1,001 - $15,000
- Lisa C. McClainhouse · MI09 · disclosed Sep 15, 2025 (27d later)Buy$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (259d later)Sell$1,001 - $15,000
- Val Hoylehouse · OR04 · disclosed Sep 12, 2025 (318d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jun 30, 2025 (46d later)Buy$1,001 - $15,000
- Jared Moskowitzhouse · FL23 · disclosed Jun 30, 2025 (46d later)Buy$1,001 - $15,000
- Julie Johnsonhouse · TX32 · disclosed May 15, 2025 (38d later)Sell$1,001 - $15,000
- Robert P. Bresnahanhouse · PA08 · disclosed Mar 28, 2025 (31d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Nov 11, 2024 (27d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Jul 8, 2024 (26d later)Sell$1,001 - $15,000
- Josh Gottheimerhouse · NJ05 · disclosed Apr 7, 2024 (37d later)Sell$1,001 - $15,000
- Ro Khannahouse · CA17 · disclosed Mar 6, 2024 (22d later)Buy$1,001 - $15,000
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
